Research Options: Select below IPO Calendar	Week of Expected Pricing Pending Company Name Peplin Inc. Proposed Ticker PLIN CUSIP 713352102 Business Description A development stage specialty pharmaceutical company focused on advancing and commercializing innovative medical dermatology products. Lead Underwriter Merrill Lynch & Co. Co-Managers Cowen and Company,Thomas Weisel Partners LLC, Leerink Swann & Company, Wilson HTM Initial Shares N/A Revised Initial Shares N/A Initial Price N/A Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.